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Abstract
Background: Step-count monitors (pedometers, body-worn trackers and smartphone applications) can increase
walking, helping to tackle physical inactivity. We aimed to assess the effect of step-count monitors on physical
activity (PA) in randomised controlled trials (RCTs) amongst community-dwelling adults; including longer-term
effects, differences between step-count monitors, and between intervention components.
Methods: Systematic literature searches in seven databases identified RCTs in healthy adults, or those at risk of disease,
published between January 2000–April 2020. Two reviewers independently selected studies, extracted data and assessed
risk of bias. Outcome was mean differences (MD) with 95% confidence intervals (CI) in steps at follow-up between
treatment and control groups. Our preferred outcome measure was from studies with follow-up steps adjusted for
baseline steps (change studies); but we also included studies reporting follow-up differences only (end-point studies).
Multivariate-meta-analysis used random-effect estimates at different time-points for change studies only. Meta-regression
compared effects of different step-count monitors and intervention components amongst all studies at ≤4months.
Results: Of 12,491 records identified, 70 RCTs (at generally low risk of bias) were included, with 57 trials (16,355 participants)
included in meta-analyses: 32 provided change from baseline data; 25 provided end-point only. Multivariate meta-analysis of
the 32 change studies demonstrated step-counts favoured intervention groups: MD of 1126 steps/day 95%CI [787, 1466] at
≤4months, 1050 steps/day [602, 1498] at 6months, 464 steps/day [301, 626] at 1 year, 121 steps/day [− 64, 306] at 2 years
and 434 steps/day [191, 676] at 3–4 years. Meta-regression of the 57 trials at ≤4months demonstrated in mutually-adjusted
analyses that: end-point were similar to change studies (+ 257 steps/day [− 417, 931]); body-worn trackers/smartphone
applications were less effective than pedometers (− 834 steps/day [− 1542, − 126]); and interventions providing additional
counselling/incentives were not better than those without (− 812 steps/day [− 1503, − 122]).
Conclusions: Step-count monitoring leads to short and long-term step-count increases, with no evidence that either body-
worn trackers/smartphone applications, or additional counselling/incentives offer further benefit over simpler pedometer-
based interventions. Simple step-count monitoring interventions should be prioritised to address the public health physical
inactivity challenge.
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Introduction
Physical activity (PA) reduces all-cause mortality, and
delivers important prevention and treatment benefits for
many different physical and psychological conditions [1].
The World Health Organisation recognises physical in-
activity as an important global health challenge, with
more than a quarter of the world’s population not meet-
ing current PA recommendations for health [1].
PA interventions can help tackle this global burden,
with those employing behaviour change techniques being
more effective [2]. Walking is the commonest PA and is
an ideal behaviour for interventions to target as: both in-
tensity and frequency can be gradually increased; it pro-
vides dynamic aerobic activity with minimal adverse
effects [3]; and it can be a good way to achieve the PA
guidance of 150min of weekly moderate-to-vigorous PA
[1, 4]. Different health drives to promote PA using walk-
ing, include campaigns to promote 10,000 steps per day
[5], or adding in 3000 steps in 30min to usual PA [6], with
a recognition that for most people walking at a moderate
intensity approximates to 1000 steps in 10min [6].
Pedometers use body-worn motion sensors to object-
ively measure step-counts and are a simple, inexpensive
intervention to increase PA levels [5]. Other monitors
have gained popularity recently, due to technological ad-
vances and their ability to capture more data. These in-
clude accelerometers, measuring acceleration forces,
incorporated into newer fitness technologies, such as
body-tracking devices and smartphone applications, also
providing objective PA measures, including step-counts
[7]. Earlier systematic reviews and meta-analyses, focus-
sing on pedometers, have highlighted significant in-
creases in PA associated with their use [8, 9]. However,
since these reviews, a number of larger randomized con-
trolled trials (RCTs) with longer follow-up have been
published [10–12]. Moreover, many trials incorporated
within the earlier reviews included subjective self-report
questionnaire outcomes, prone to particular biases [13]
and with considerable over-reporting of PA compared to
objective PA measures [14]. Finally, the effectiveness of
newer fitness technologies, including body-worn track-
ing devices and smartphone applications in increasing
PA levels needs to be explored systematically.
Thus, the main aim of this review was to examine the
effects of step-count monitoring devices (pedometers,
body-worn trackers and smartphone applications) on
objectively measured step-counts among the adult gen-
eral population.
Specific objectives were:
 To determine whether intervention effects varied
with length of follow-up;
 To determine whether certain types of intervention
were more effective than others (for example,
studies reporting change in PA from baseline
compared to end-point only, pedometers compared
to other step-count monitors, and interventions pro-
viding additional counselling/incentives compared to
those not).
Methods
Our systematic review was performed and reported in
accordance with the 2009 PRISMA statement [15].
Search strategy
We searched for articles indexed in Ovid Medline,
EMBASE, PsycINFO, Web of Science, Cochrane Library,
CINAHL and ASSIA that were published from January
2000 using a combination of controlled vocabulary (for
example, Medical Subject Headings (MeSH)) and key-
word searching. RCTs published after the year 2000
were selected due to the emerging technology of meas-
uring step-counts amongst the general population from
this time onwards. The initial search was conducted in
September 2017, with a forward citation search of in-
cluded studies conducted in June 2018, and an updated
search carried out in April 2020, to incorporate the most
recent evidence and to ensure longer follow-up periods
were included. Further studies were selected after exam-
ining the references of included studies and from earlier
systematic review. Search strategies are provided for
MEDLINE [Additional file 1] and other databases
[Additional file 2].
Study selection, inclusion and exclusion criteria
Study inclusion and exclusion criteria were developed in
accordance with the PICOS framework [15, 16] and are
fully described in Additional file 3. We included RCTs
involving adults, published in English-language. Cluster
randomised trials were eligible, as were cross-over stud-
ies, providing data were available at the end of the first
phase to avoid possible intervention carry-over effects.
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Studies of healthy adults, those at risk of disease, or
those with pre-existing chronic medical conditions (ei-
ther physical or psychological) as expected within a gen-
eral population were included. Studies were excluded if
participants were hospital or institution-based, selected
on the basis of a health condition; or involved high-
performance training. Community-based programmes
including step-count monitoring interventions (pedome-
ters, other body-worn fitness devices and smartphone
applications) and providing objectively measured step-
count outcomes, either with change in step-count from
baseline (change-on-change) or with only step-counts at
follow-up (end-point only) were included. The interven-
tion could feature any form of pedometer or any other
device, either physical or electronic, which measured the
user’s step-count, including mobile phone applications
and common body-worn fitness devices. Outcomes re-
ported at all time-points following intervention comple-
tion were included. Where studies had more than one
step-count monitoring intervention, all were selected.
Comparators included control group participants pre-
dominantly receiving ‘usual standard care’ or healthcare
advice with minimal active engagement (that is, not
using a step-count monitoring device). Where there was
more than one control group, the one with least active
engagement was selected. This review focussed on RCTs
as these are considered the gold-standard for assessing
interventions; randomisation, when correctly imple-
mented, eliminates bias in treatment assignment and
limits confounding. The search was restricted to
English-language studies due to the lack of funding, as
specified in our protocol.
References were initially managed using EndNote
X7.7.1 [17], where duplicates were removed. We applied
an RCT classifier [18] and studies deemed to have a ≤
5% chance of being an RCT were excluded, after valid-
ation on a 5% sample. The RCT classifier works by uti-
lising a machine learning algorithm to accurately
identify randomised controlled trials [18]. This was pos-
sible for the initial search conducted in September 2017,
but was not available for the later updated search con-
ducted in April 2020. Two review authors then inde-
pendently screened the remaining titles and abstracts
using an inclusion check-list [Additional file 4] and Ray-
yan (a web application to rapidly screen a large number
of records for selection) [19]. Full-texts of potentially eli-
gible studies were obtained and assessed by two authors
independently, with discrepancies resolved through dis-
cussion and consultation with the wider author team
(RF / TH / DC).
Data extraction
Data on characteristics of included studies were inde-
pendently extracted by two reviewers (UC and RK) using
a pre-piloted data extraction sheet. Data included: 1)
study design, total participants, participant demographic
details, follow-up length; 2) intervention details; 3) out-
come measures. Where further clarification was required
regarding data, study authors were contacted to provide
this information. The collected data for the 32 studies
which provided mean between-group difference in
change from baseline step-count (change-on-change)
and the 25 studies which provided end-point only step-
counts are provided in Additional file 5.
Risk of bias assessment
The risk of bias was assessed independently for each
study by two reviewers independently, using the
Cochrane Risk of Bias tool [16]. Disagreements were re-
solved through discussion with a third author (RF). A
sensitivity analysis based on the Risk of Bias score was
not performed, as this was not pre-specified in the
protocol.
Differences from published protocol
Compared to the outlined protocol, one of the secondary
objectives focusing on different sub-groups based on
demographics was not undertaken due to the lack of suf-
ficient data in many studies. Nor did we analyse data on
moderate-to-vigorous physical activity (MVPA) as a sec-
ondary outcome; this was problematic due to the
heterogenous reporting of MVPA outcomes and was un-
necessary because of the ubiquitous availability of step-
count data.
Data analysis
The primary outcome was step-count, reported with 95%
confidence intervals (CI). We preferred change in step
count from baseline as we anticipated within-person
scores to be correlated and that change would result in
greater precision and be less prone to bias, since individ-
uals are used as their own controls, than studies based on
measurements at follow-up only. If both change from
baseline and end-point scores were available, we extracted
both. If available, we preferentially used analysis of co-
variance (ANCOVA) measures of change in our meta-
analyses. For trials with multiple relevant intervention
arms, we performed adjustments to the data before per-
forming the meta-analysis, by splitting the comparator
group to avoid double-counting. The I2 statistic was used
to measure the heterogeneity [20].
Initial meta-analyses were performed and Forest plots
created using RevMan 5.3 [21]. As we expected to find
between-study heterogeneity, random-effects models
were used for the meta-analysis. Potential publication
bias was assessed using funnel plots, with sub-setting of
the estimates by time of follow-up from randomisation.
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We performed sub-group analyses for different follow-
up periods and meta-regression (described in more de-
tail below) to explore: 1) study outcome type (that is,
change-on-change versus end-point studies); 2) type of
monitor (that is, pedometer-based interventions versus
other step-count monitoring interventions such as body-
worn trackers and smartphone applications); and 3) in-
tensity of intervention (that is, comparing interventions
additionally offering individual / group counselling or fi-
nancial incentives, with those that did not). We were un-
able to explore effect modification by demographic
variables or to compare interventions with different con-
tact lengths/ intensities due to the diversity and lack of
reporting of these variables.
Additional meta-analyses were carried out using the
Stata procedure Mvmeta [22, 23]. Specifically: (i) analysis
of estimates changing over time was assessed using
multivariate meta-analysis which formally allowed for
the same studies appearing at different time points – the
outcome was a matrix of 5 variables, with each column
corresponding to one of the 5 time points and each row
corresponding to a study. Studies contributed data at
variable numbers of time points; a-priori we decided that
this analysis should be restricted to studies providing
change-on-change estimates as the correlation between
different time points would differ in end-point only
studies; (ii) multi-variable meta-regression was carried
out at the first time point (≤4 months) to assess whether
estimates of effect varied, as described above, by: study
outcome type; type of monitor used; and intervention in-
tensity. Details of the Mvmeta options used are given in
Additional file 6.
Our review protocol was registered with PROPERO




The PRISMA flow diagram for study selection can be
seen in Fig. 1. 25,922 studies were initially identified
using database searching in September 2017, forward
citation search in June 2018, updated search in April
2020 and from previous systematic reviews, of which
14,423 records remained after removal of duplicates.
After application of an RCT classifier 12,491 studies
remained eligible for title/abstract screening, of which
498 full-texts were subsequently reviewed. 70 studies
met the inclusion for the systematic review.
Fig. 1 PRISMA Flowchart Screening of Literature Search and Eligibility
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Fig. 2 Risk of Bias Decisions for Change-on-Change and End-Point Only Outcome Studies. a Change-on-Change Outcome Studies. b End-Point
Only Outcome Studies
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Fig. 3 Mean between-group difference in change from baseline step-count (32 studies)
Chaudhry et al. International Journal of Behavioral Nutrition and Physical Activity          (2020) 17:129 Page 6 of 16
Therefore, 70 studies were included as part of this sys-
tematic review, of which:
 32 studies provided data on mean between-group
difference in change from baseline step-count
(“change-on-change studies”) [10–12, 24–52];
 25 studies only provided data on mean between-
group difference in end-point step-count (“end-point
only studies”) [53–77];
 13 further studies did not provide data suitable for
inclusion in our meta-analyses and were included as
part of the narrative synthesis [78–90].
Study characteristics
Full details of the 57 studies included in the meta-
analyses and their study characteristics are shown in
Additional file 5 [10–12, 24–77]. The remaining 13 stud-
ies are described later (see ‘narrative only studies’ for de-
tails) [78–90].
Of the 57 RCTs included in the meta-analyses, 54
RCTs had a parallel design [10–12, 24–41, 43–57, 59–
72, 74–77]; 3 were cross-over studies [42, 58, 73]. Seven-
teen studies were conducted in the USA, 16 in the UK, 6
in Australia, 3 in Canada, Japan and Spain, 2 in Belgium,
one each in Brazil, Hong Kong, Ireland, Netherlands,
New Zealand, Singapore, and one was European-wide.
One study identified with relevant step-count outcome
data was a published abstract [64], with further details
about the study highlighted in a separate paper [91]. The
57 RCTs included 16,355 participants with reported ages
between 18 and 95 years, recruited from community-
based, primary care settings, or from their workplace.
The majority of participants in the studies providing eth-
nicity information were of white ethnicity. Participants
were ambulatory with the ability to participate in step-
count monitoring interventions. Most did not have spe-
cific risk factors, but included those at risk of developing
Type 2 Diabetes Mellitus (T2DM), overweight with a
body mass index (BMI) of ≥25 kg/m2, and those not
meeting PA recommended guidelines. Thirty-nine [10–
12, 24, 26, 33–39, 41, 42, 44, 48–50, 52, 54–60, 62, 64–
70, 72–74, 76, 77] of the 57 RCTs used pedometers; the
remaining 18 [25, 27–32, 40, 43, 45–47, 51, 53, 61, 63,
71, 75] used other step-count monitoring interventions
such as other body-worn trackers and smartphone appli-
cations. The intensity of interventions ranged from the
provision of a pedometer or other step-count monitor,
often with PA electronic/print resources, written exer-
cise programmes or on-line PA updates, to those that
additionally provided individual PA consultations, group
counselling or financial incentives [10–12, 24–77]. The
control groups received usual care or electronic / print
resources and educational sessions, but without the use
of a step-count monitoring device. Thirty-two RCTs
provided change-on-change step-count measures, 25
RCTs provided end-point only step-count measures.
The length of follow-ups ranged from 1 week to 4 years.
Risk of bias within studies
The risk of bias analysis is shown in Fig. 2. Generally,
the trials were reasonably well designed and conducted
to have a low risk of bias, particularly those reporting
change-on-change scores. This is despite the unavoid-
able risks associated with trials of behavioural interven-
tions, which cannot be blinded and so all studies were
judged to have a high risk of performance bias. Outcome
assessment risk of bias (detection bias) was however




As planned, our primary analysis of variation in inter-
vention effect during follow-up is based on the 32
change-on-change studies. Fig. 3 presents a forest plot of
the individual and pooled effect estimates for the 32
studies, stratified by time of follow-up. At ≤4 months the
pooled estimate of change indicated individuals in the
intervention group were doing significantly more steps/
day than controls: Mean difference (MD) + 1145 steps/
day [95%CI: 838 to 1451; 23 studies; I2 = 81%]. A differ-
ence favouring the intervention group was maintained at
6 months MD + 1127 steps/day [95%CI: 710, 1543; 11
studies; I2 = 75%]. At 12 months the MD was + 457
steps/day [95%CI: 281, 634; 13 studies; I2 = 57%], at 2
years MD + 66 steps/day [95% CI: − 92, 224; 4 studies;
I2 = 0%] and at 3–4 years MD + 494 steps/day [95%CI:
251, 738; 3 studies; I2 = 0%].
The multivariate results are very comparable to the
univariate estimates (Table 1), at the shorter time pe-
riods (at ≤4months MD + 1126 [CI: 787, 1466] and at
approximately 6 months MD + 1050 [602, 1498]). The 1-
year (MD + 464 [301, 626]) and 3–4 year estimates (MD
+ 434 [191, 676]) remain statistically significant in favour
of the intervention group; however, the 2-year estimate
(MD + 121 [− 64, 306]) based on four studies, one of
which has a large weighting, is not statistically significant
in favour of the intervention group.
End-point only studies
Figure 4 demonstrates the pooled effect estimates for
the 25 end-point only studies at all reported time-
points. At ≤4 months, the mean steps/day of the
intervention group was significantly greater than con-
trol group: MD + 1854 steps/day [95% CI: 1217, 2492;
23 studies; I2 = 85%]. This was maintained at approxi-
mately 6 months with an MD + 885 steps/day [95%
CI: − 354, 2125; 4 studies; I2 = 70%], albeit without
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Table 1 Analysis of Change-on-Change Studies at different Time-points: comparison of univariate analyses at each time-point with a
multivariate analysis allowing for correlation of outcomes at different time-points
Follow-up Period Separate Meta-analysis at Time-point
Mean Difference [95% CI]
Multivariate Meta-analysis across Time-points
Mean Difference [95% CI]
≤ 4 months 1172 [815, 1528] 1126 [787, 1466]
Approximately 6 months 1156 [672, 1641] 1050 [602, 1498]
1 year 458 [277, 638] 464 [301, 626]
2 years 66 [−92, 224] 121 [−64, 306]
3–4 years 494 [251, 738] 434 [191, 676]
Both Univariate and Multivariate models fitted using REML as MM option not available for multivariate model
Fig. 4 Mean between-group difference in end-point step-count (25 studies)
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reaching levels of significance, and at 12 months with
a MD 1381 steps/day [95% CI: 377, 2386; 2 studies;
I2 = 25%]. No follow-up data were available for end-
point only studies beyond 1 year.
Analysis of outcomes at ≤4months based on all study
outcome type (change-on-change and end-point only studies)
Figure 5 shows the funnel plot of change-on-change
studies and end-point only studies at ≤4 months and
demonstrates slight asymmetry.
Given the clear effect of time of follow-up on effect es-
timates and that the majority of studies reported effects
at ≤4 months, we carried out meta-regression at ≤4
months’ time-frame only; the results are presented in
Table 2. In keeping with the forest plot, end-point only
studies reported bigger effect estimates than change-on-
change studies, but this difference was not statistically
significant: MD 616 steps [95%CI [− 92, 1324]. This ef-
fect was more than halved when mutually adjusted for
‘type of monitor’ and ‘intensity of intervention’: MD 257
[− 417, 931]. Studies using other step-count monitoring
interventions (such as body-worn trackers and smart-
phone applications) reported lower treatment effects
than those using pedometer-based interventions re-
ported larger; MD − 927 steps [− 1633, − 190]; the effect
was little affected by mutual adjustment for ‘study out-
come type’ and ‘intensity of intervention’ (MD − 834
steps [− 1542, − 126]. Finally, studies which we rated as
having higher intensity interventions (for example, those
including additional PA individual or group counselling
or financial incentives) had lower average effect esti-
mates than those studies not using counselling or offer-
ing other incentives: MD -931 [− 1623, − 239], and this
was slightly reduced by mutual adjustment for ‘study
outcome type’ and ‘type of monitor’: MD -812 [− 1503,
− 122]. A sensitivity analysis excluded 2 studies where
the intervention was a smartphone only, with no body
worn tracker [32, 46]; this made minimal difference to
the estimate for other (body worn) step-count monitor-
ing interventions, which still remained significantly
lower than for pedometers.
Narrative only studies
Thirteen studies were included in our systematic review,
but were not included as part of the meta-analysis.
Three studies provided insufficient overall intervention
or control group data, and instead provided only sub-
group analyses [78–80]; two of these studies concluded
in favour of utilising step-count monitoring interven-
tions to increase overall PA [78, 79], however the third
study concluded that there was no evidence of efficacy
[80]. A further multi-intervention arm study which pro-
vided data in the form of relative change scores also
highlighted the use of a pedometer as a sufficient tool to
increase steps [81]. Four studies were cross-over studies
and did not provide data at the end of the first period
[82–85]; there were inconsistent findings with studies
reporting significant favourability towards utilising step-
count monitoring interventions [82–84], and some
reporting no significant differences between intervention
Fig. 5 Funnel Plot of Studies reporting Mean-differences of Change-on-Change Study Outcome and End-point Only Study Outcome at
≤4 months Time-point
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and control groups [85]. The remaining five studies pre-
sented data graphically using either scatter graphs or bar
charts, and all provided evidence to suggest that the
intervention group incorporating step-count monitoring
devices significantly increased the step-count at different




The use of community pedometer-based or other step-
count monitoring interventions compared to usual care is
associated with a significant increase in step-count when
assessed using both change from baseline scores and end-
point only scores. The greatest difference in steps is seen
at the shortest follow-up period at ≤4months, with inter-
vention participants in change-on-change studies walking
on average 1126 more steps/day. This significant improve-
ment in step-count remains at approximately 6months
and 1 year with step-count monitoring interventions pro-
viding 1050 and 464 additional steps/day respectively. This
overall improvement in steps is maintained at longer-term
follow-up periods with differences of 121 steps/day at 2
years without reaching levels of significance and 434
steps/day at 3–4 years. Studies that presented outcome
data using end-point only step-counts broadly supported
these findings from change-on-change studies, but pro-
vided no data beyond 1 year. Our meta-regression ana-
lyses strongly suggest that newer devices such as body-
worn trackers and smartphone applications are less advan-
tageous than simpler pedometers, while interventions in-
cluding individual or group counselling, or financial
incentives, also offered no additional step-count benefit
compared to those interventions without. Taken together
these findings suggest that simple pedometer-based inter-
ventions can lead to both short and long-term PA
increases and should be considered more widely for public
health PA promotion.
Study strengths and weaknesses
There are several strengths to this systematic review and
meta-analysis. We followed PRISMA guidance and pro-
spectively published our protocol. We were able to in-
corporate recent larger trials that had not been
previously included in systematic reviews. Our review in-
corporated data from over 16,000 participants from 70
eligible studies (57 studies included in meta-analyses) to
provide robust conclusions about the effect of step-
count monitoring interventions. We also incorporated
different methods of measuring our primary outcome,
using both change from baseline and end-point only
daily step-count measurements, allowing us to combine
more studies and to further strengthen our conclusions.
Given that the vast majority of studies had an interven-
tion period of approximately 3 months, and the availabil-
ity of data at 1 year and beyond, our analyses provide
clear evidence of maintenance of an effect many months
after the intervention has finished. The risk of bias as-
sessment demonstrated that most studies, particularly
those reporting change-on-change scores, used appropri-
ate methods to minimise bias, despite the challenges
with blinding such interventions. An updated search car-
ried out in April 2020, ensures that this review captures
the most recent data relevant for this systematic review.
To our knowledge, this is the first review to directly
compare the effectiveness of body worn devices and
smartphone applications with traditional pedometers in
general population samples.
There are also limitations to consider. Since all studies
had unblinded participants, the risk of performance bias
was judged high, although this is a universal issue with
such interventions. Moreover, we were confident that
Table 2 Univariate Meta-regression Analysis at First Time Point (≤4 months) to Investigate Effect-Modifiers







between Effect Modifier Groups
Mean [95% CI]
Study Outcome Type Change-on-Change Studies 1215 [737, 1692]
End-point Only Studies 1831 [1307, 2355] 616 [−92, 1324] 257 [−417, 931]
Type of Monitor Pedometer 1716 [1303, 2129]
Other Step-count Monitoring
Interventions
789 [178, 1401] −927 [−1633, −190] −834 [−1542, −126]
Intensity of Interventiona Intervention without PA
individual or group counselling
2067 [1520, 2614]
Intervention with PA individual
or group counselling or other
incentives (e.g. cash or charity)
1136 [711, 1561] −931 [−1623, −239] −812 [−1503, −122]
a4 studies had missing grade
Above all based on REML models. Using mm2 model has little impact on meta-regression
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due to the objective outcome measures the risk of detec-
tion bias was low. Further evidence to support this
comes from trials that have increased step-counts in the
long term and have also reduced important clinical out-
comes such as fractures and cardiovascular events [92].
Many studies did not mention the theoretical underpin-
ning underlying their behavioural change interventions,
and as such we felt that it would be difficult to compare
the effect of different studies on this basis. We also ex-
plored the potential of publication bias using a funnel
plot; the slight asymmetry, particularly amongst the end-
point only studies, indicated that smaller, shorter trials
with positive results may have been preferentially pub-
lished. We feel however, that this would have had only a
small impact on our overall findings and it confirmed
our preference for change-on-change step-count data as
our main analysis. We recognize that there was a high
degree of statistical heterogeneity, especially at the short
follow-up periods, probably due to the considerably var-
ied nature of the study designs and different intervention
types.
At the 2-year time-point, the estimated treatment
effect is not statistically significant; this is mainly due
to the Ismail et al study, which has a weighting of
65.9% within this follow-up period [36]. This study
was not effective at increasing step-counts at either
the 1 year or 2-year follow-up points, for which the
authors offer several explanations [36]. There was a
lack of engagement with the intervention with a delay
between randomisation and intervention commence-
ment [36]. Of participants randomised to the two in-
terventions, 28% did not start the intervention, while
an additional 17% did not complete it [36]. Loss to
follow-up at 24 months was also significantly higher
in the intervention groups than the usual care group
[36]. The authors speculated that study fatigue might
explain this lack of engagement; interventions in-
volved 10 sessions as well as considerable data collec-
tion at baseline 12 and 24 months [36]. This analysis
of an unsuccessful complex intervention further
strengthens our key conclusion that simple step-count
monitoring interventions need to be prioritised.
An important limitation of all meta-regressions is
that they are essentially observational comparisons of
different trials and lack the formal rigour of within
trial randomised comparisons. In the future, trials
may compare different types of interventions by ran-
domising within trial; any such trials will be better in-
formed by the between trial comparisons we have
presented. Unfortunately, many studies provided in-
complete information about some aspects of the in-
terventions such as the number and lengths of
contacts, so this could not be formally analysed. Our
analysis of intensity of intervention only included
whether individual or group counselling or other in-
centives were offered, not the number nor length of
contacts. We did not seek to obtain individual partici-
pant data and so were unable to explore other poten-
tial within trial effect modifiers, especially those
related to demographic variables such as age, gender
and socio-economic status. Finally, the studies were
mostly conducted in high income countries and re-
cruited participants of white ethnicity, so the results
may not be as applicable to other countries and other
ethnic groups.
Comparison with other studies
Two previous systematic reviews focussed solely on
pedometer-based interventions [8, 9]. Kang et al combined
observational and randomised studies in both adults and
children and reported a short-term increase of approxi-
mately 2000 steps/day [8]. Bravata et al demonstrated an
improvement of 2491 steps/day in RCTs in adults; how-
ever, the trials included were small (maximum of 51 sub-
jects randomised) and half were based on subjects with
serious chronic diseases, which may not be generalizable
[9]. Apart from inclusion of observational studies and a
focus on specific diseases, other reasons that their esti-
mates of effect were greater than our own, may include
self-reported PA measures in some of their trials and
small sample sizes [8, 9]. Our more conservative estimate
of change in step-counts is potentially less biased, due to
inclusion of larger RCTs, with longer follow-up periods
and only using objectively measured outcomes. Other re-
views included pedometer-based and other broader phys-
ical activity interventions (though not body-worn trackers
or smartphone applications) with both objective and self-
reported PA measures [93–95]. Hobbs et al found no rela-
tionship between intervention effectiveness and the num-
ber of intervention contacts or mode of delivery and
found only limited PA data beyond 12months [95]. Our
review therefore builds on previous work on step-count
monitors, by focusing solely on objective physical activity
measures in the adult general population, and including a
number of recently published larger trials with longer
follow-up periods [10–12] and trials of body-worn fitness
trackers [25, 27–29, 40, 43, 45, 47, 51, 53, 61, 63, 71, 75]
or smartphone only applications [30–32, 46] or combined
[25, 28, 40, 47, 53, 63, 71].
A very recent meta-analysis focussing on pedometer-
based and accelerometer-based PA interventions
amongst adults with cardio-metabolic conditions dem-
onstrated small to medium PA level improvements [96].
Although this review had few long-term follow-up trials,
it highlighted that pedometer-based interventions had
improved association with PA as compared to
accelerometer-based interventions [96], which is consist-
ent with our findings comparing pedometer
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interventions with other body-worn monitors and smart-
phone applications. However, it demonstrated that the
greatest increases in PA levels was achieved by more
complex interventions, with regular contact with health-
care professionals, which differs from our own meta-
regression analysis [96]. This may in part be due to our
different definitions of complexity as well as to the dif-
ferent study populations; their study focused on adults
with cardio-metabolic conditions, whilst ours focussed
on the general population. It is worth emphasising that
only 2 studies were included in both reviews [12, 60]. A
further recent review of consumer-based wearable activ-
ity trackers (not pedometers), also demonstrated in-
creases in steps of 500–600/day compared to controls,
but did not provide any comparison with pedometer in-
terventions and lacked long term data [97].
Implications for public health research, practice and
policy
From a research perspective, our review highlights two
problems of inconsistent outcome reporting amongst
RCTs. Some studies provided only graphical presenta-
tion of step-count results, which prevented their inclu-
sion in meta-analyses. We were also unable to analyse
the importance of both number and length of interven-
tion sessions, due to reporting inconsistencies, which
others have also highlighted [96]. Moving forward, there-
fore, when interventions are being investigated, it is im-
portant for study reports to provide clear information
about the exact nature of the intervention, the number
and length of contacts included within it and the report-
ing of outcomes, to provide further robust evidence to
inform policy.
This review demonstrated that step-count monitoring
interventions can lead to sustained increases in people’s
walking, but that fitness trackers and smartphone appli-
cation offered no clear advantage over simpler
pedometer-based interventions. It is important to con-
sider why this might be. Step-count monitoring inter-
ventions which have been shown to be particularly
effective in long-term PA change, encompass behav-
ioural change techniques, including goal setting, self-
monitoring and feedback [98]. Pedometers can effect-
ively provide this simple self-monitoring information
with an easily understandable output [5, 98]. Fitness
trackers also incorporate distance walked, elevation, the
physical activity intensity, heart rate, rewards and social
participation, amongst other features and have poten-
tially been shown to be superior to pedometers [98].
However, when focussing on walking and increasing
step-counts, small and simple goals may be more effect-
ive for long-term engagement of larger goals [98]. The
‘3,000 steps in 30 minutes’ is becoming an ever-
increasing public health initiative [6], which is easily
accomplished using a pedometer; more complex infor-
mation is not required and may in fact detract from the
simple message. In addition, provision of additional indi-
vidual or group counselling or financial incentives also
did not provide further benefit over simple step-count
monitoring interventions, suggesting that a ‘less is more’
approach might be more suitable for walking interven-
tions in community-based populations. This also has
cost-effectiveness advantages [99], with positive implica-
tions for those commissioning PA interventions and
services.
From a public health policy and practice perspective
what does a long-term improvement of 434 steps per
day at 3–4 years mean? Clear dose-response associations
have been reported between increases in step-counts
and reduced mortality, with 1000 extra steps/day being
associated with a 15% lower risk in older men [100] and
a 6% reduction in younger cohorts of men and women
[101]. A recent meta-analysis also showed a clear dose-
response association between accelerometer measured
PA and all-cause mortality, with clear evidence that the
strongest benefits were seen at lower PA levels, for all
activity intensities [102]. Therefore, there is evidence to
suggest that any form of activity, either moderate or
lighter levels are still associated with improved mortality
benefit [102–104], and this is reflected within recent PA
guidance [4]. This has been further corroborated by a re-
cent large population-based cohort study, which has
highlighted that engaging in leisure time aerobic activity
and meeting national PA guidelines reduces all-cause
and cause-specific mortality [105]. Observational studies
such as those above [100–105] are problematic however,
in terms of potential reverse causality; so findings from
two recent pedometer-based RCTs that demonstrated
significant effects on clinical outcomes, with reductions
in both cardiovascular events and fractures for an ap-
proximate increase of 400–600 steps per day 3–4 years
post-intervention, provide reassuring support for these
findings [92].
Conclusions
Physical inactivity is an important public health con-
cern and our findings strengthen the evidence that
step-count monitoring interventions can improve long-
term PA levels in adults. There was no clear advantage
of newer body-worn trackers or smartphone applica-
tions over simple pedometers, and no evidence that
additional individual or group counselling improved
outcomes. These findings have important implications
for those wishing to use PA interventions to address
the public health inactivity challenge and suggest that
simple pedometer-based walking interventions should
be prioritised.
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